Source: Scientific Reports. Unidade: FCFRP
Subjects: ANTINEOPLÁSICOS, FARMACOLOGIA, APOPTOSE, LINHAGEM CELULAR, PROLIFERAÇÃO CELULAR, DANO AO DNA, LEISHMANIA, METABOLISMO, NEOPLASIAS PULMONARES, QUIMIOTERAPIA, ESPÉCIES REATIVAS DE OXIGÊNIO, RUTÊNIO
ABNT
COSTA, Mônica Soares et al. Ruthenium (II) complex cis-[RuII(ŋ2-O2CC7H7O2)(dppm)2]PF6-hmxbato induces ROS-mediated apoptosis in lung tumor cells producing selective cytotoxicity. Scientific Reports, v. 10, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-72420-w. Acesso em: 10 nov. 2024.APA
Costa, M. S., Gonçalves, Y. G., Borges, B. C., Silva, M. J. B., Amstalden, M. K., Costa, T. R., et al. (2020). Ruthenium (II) complex cis-[RuII(ŋ2-O2CC7H7O2)(dppm)2]PF6-hmxbato induces ROS-mediated apoptosis in lung tumor cells producing selective cytotoxicity. Scientific Reports, 10. doi:10.1038/s41598-020-72420-wNLM
Costa MS, Gonçalves YG, Borges BC, Silva MJB, Amstalden MK, Costa TR, Antunes LMG, Rodrigues RS, Rodrigues V de M, Franca E de F, Zóia MAP, Araújo TG de, Goulart LR, Von Poelhsitz G, Yoneyama KAG. Ruthenium (II) complex cis-[RuII(ŋ2-O2CC7H7O2)(dppm)2]PF6-hmxbato induces ROS-mediated apoptosis in lung tumor cells producing selective cytotoxicity [Internet]. Scientific Reports. 2020 ; 10[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/s41598-020-72420-wVancouver
Costa MS, Gonçalves YG, Borges BC, Silva MJB, Amstalden MK, Costa TR, Antunes LMG, Rodrigues RS, Rodrigues V de M, Franca E de F, Zóia MAP, Araújo TG de, Goulart LR, Von Poelhsitz G, Yoneyama KAG. Ruthenium (II) complex cis-[RuII(ŋ2-O2CC7H7O2)(dppm)2]PF6-hmxbato induces ROS-mediated apoptosis in lung tumor cells producing selective cytotoxicity [Internet]. Scientific Reports. 2020 ; 10[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/s41598-020-72420-w